🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the makers of Tylenol, alleging the companies withheld alleged dangers that the pain reliever presented to children's brain development.

The lawsuit arrives four weeks after President Donald Trump publicized an unproven link between taking Tylenol - also known as acetaminophen - throughout gestation and autism in children.

The attorney general is filing suit against J&J, which previously sold the drug, the exclusive pain medication approved for women during pregnancy, and Kenvue, which presently makes it.

In a declaration, he claimed they "deceived the public by profiting off of suffering and promoting medication regardless of the potential hazards."

Kenvue says there is lacking scientific proof connecting Tylenol to autism spectrum disorder.

"These manufacturers misled for generations, knowingly endangering countless individuals to boost earnings," Paxton, a Republican, stated.

Kenvue said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the reliability of paracetamol and the potential impact that could have on the well-being of American women and children."

On its online platform, Kenvue also said it had "regularly reviewed the relevant science and there is no credible data that demonstrates a proven link between taking paracetamol and autism spectrum disorder."

Associations representing doctors and medical practitioners share this view.

The American College of Obstetricians and Gynecologists has stated paracetamol - the main ingredient in acetaminophen - is a restricted selection for expectant mothers to manage pain and elevated temperature, which can pose serious health risks if not addressed.

"In more than two decades of studies on the use of paracetamol in pregnancy, zero credible investigations has successfully concluded that the use of acetaminophen in any stage of gestation results in neurological conditions in children," the association stated.

The court filing mentions latest statements from the Trump administration in arguing the medication is potentially dangerous.

In recent weeks, Trump generated worry from medical authorities when he instructed pregnant women to "resist strongly" not to consume Tylenol when unwell.

The FDA then released a statement that medical professionals should consider limiting the usage of acetaminophen, while also mentioning that "a direct connection" between the medication and autism spectrum disorder in young ones has not been established.

Health Secretary Robert F Kennedy Jr, who supervises the Food and Drug Administration, had promised in April to undertake "extensive scientific investigation" that would identify the cause of autism in a limited time.

But authorities cautioned that identifying a single cause of autism spectrum disorder - thought by researchers to be the outcome of a intricate combination of inherited and surrounding conditions - would not be simple.

Autism spectrum disorder is a category of permanent neurological difference and condition that affects how people experience and interact with the surroundings, and is recognized using physician assessments.

In his lawsuit, Paxton - who supports Trump who is seeking US Senate - asserts the manufacturer and Johnson & Johnson "intentionally overlooked and tried to quiet the science" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the firms "eliminate any commercial messaging" that states Tylenol is safe for pregnant women.

The Texas lawsuit mirrors the concerns of a assembly of parents of children with autism and attention deficit hyperactivity disorder who took legal action against the makers of Tylenol in two years ago.

A federal judge rejected the legal action, stating research from the plaintiffs' authorities was not conclusive.